Nebula Research & Development’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.98M | Buy |
36,071
+18,171
| +102% | +$999K | 0.17% | 193 |
|
2025
Q1 | $1.27M | Sell |
17,900
-25,285
| -59% | -$1.79M | 0.12% | 288 |
|
2024
Q4 | $2.84M | Sell |
43,185
-9,514
| -18% | -$625K | 0.33% | 54 |
|
2024
Q3 | $3.7M | Buy |
+52,699
| New | +$3.7M | 0.44% | 14 |
|
2024
Q2 | – | Sell |
-5,114
| Closed | -$447K | – | 813 |
|
2024
Q1 | $447K | Buy |
+5,114
| New | +$447K | 0.1% | 397 |
|